Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Amylyx Pharmaceuticals Inc (AMLX)

Amylyx Pharmaceuticals Inc (AMLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 124,451
  • Shares Outstanding, K 68,006
  • Annual Sales, $ 380,790 K
  • Annual Income, $ 49,270 K
  • 60-Month Beta -0.68
  • Price/Sales 0.33
  • Price/Cash Flow 3.06
  • Price/Book 0.38
Trade AMLX with:

Options Overview Details

View History
  • Implied Volatility 63.79% ( -49.98%)
  • Historical Volatility 65.72%
  • IV Percentile 25%
  • IV Rank 3.63%
  • IV High 504.90% on 04/09/24
  • IV Low 47.15% on 09/14/23
  • Put/Call Vol Ratio 0.04
  • Today's Volume 618
  • Volume Avg (30-Day) 572
  • Put/Call OI Ratio 0.37
  • Today's Open Interest 105,287
  • Open Int (30-Day) 106,414

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.38
  • Number of Estimates 2
  • High Estimate -0.24
  • Low Estimate -0.52
  • Prior Year 0.31
  • Growth Rate Est. (year over year) -222.58%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.7000 +7.65%
on 04/26/24
2.1300 -14.08%
on 05/03/24
-0.1700 (-8.50%)
since 04/17/24
3-Month
1.7000 +7.65%
on 04/26/24
19.9488 -90.83%
on 02/29/24
-14.0500 (-88.48%)
since 02/16/24
52-Week
1.7000 +7.65%
on 04/26/24
27.9900 -93.46%
on 05/18/23
-25.9600 (-93.41%)
since 05/17/23

Most Recent Stories

More News
Stocks Give Up Early Gains and Close Lower as Chip Stocks Retreat

The S&P 500 Index ($SPX ) (SPY ) Friday closed down -0.65%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.18% and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -1.53%. Stock indexes...

$SPX : 5,303.27 (+0.12%)
SPY : 529.45 (+0.14%)
$DOWI : 40,003.59 (+0.34%)
DIA : 399.95 (+0.33%)
$IUXX : 18,546.23 (-0.06%)
QQQ : 451.76 (-0.05%)
ZNM24 : 109-060s (-0.27%)
COST : 795.81 (+0.35%)
MRVL : 71.92 (-1.59%)
AVGO : 1,395.29 (-1.19%)
MDB : 370.82 (+0.24%)
NVDA : 924.79 (-1.99%)
Stocks Slide After U.S. Unemployment Report

The S&P 500 Index ($SPX ) (SPY ) is down -0.43%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.04%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.82%. Stock indexes are lower this afternoon,...

$SPX : 5,303.27 (+0.12%)
SPY : 529.45 (+0.14%)
$DOWI : 40,003.59 (+0.34%)
DIA : 399.95 (+0.33%)
$IUXX : 18,546.23 (-0.06%)
QQQ : 451.76 (-0.05%)
ZNM24 : 109-060s (-0.27%)
CCL : 15.00 (+0.67%)
RCL : 141.92 (-0.66%)
NCLH : 15.75 (-0.88%)
AMD : 164.47 (+1.14%)
NVDA : 924.79 (-1.99%)
Stocks Gain as U.S. Unemployment Report Bolsters the Outlook for Fed Rate Cuts

The S&P 500 Index ($SPX ) (SPY ) this morning is up +0.21%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.35%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.29%. Stock indexes this morning...

$SPX : 5,303.27 (+0.12%)
SPY : 529.45 (+0.14%)
$DOWI : 40,003.59 (+0.34%)
DIA : 399.95 (+0.33%)
$IUXX : 18,546.23 (-0.06%)
QQQ : 451.76 (-0.05%)
ZNM24 : 109-060s (-0.27%)
NVDA : 924.79 (-1.99%)
GE : 159.89 (-0.76%)
BIIB : 230.57 (+0.23%)
IOT : 40.90 (+0.69%)
DOCU : 60.22 (+0.53%)
2 Biotech Stocks With Huge Catalysts in 2024

Important clinical-trial readouts on the way could send these stocks soaring in early 2024.

CRSP : 56.22 (+0.99%)
VRTX : 445.21 (+1.04%)
AMLX : 1.8300 (unch)
3 Under-the-Radar Biotech Stocks to Buy in 2023

These three lesser-known biotech companies are profitable and growing revenue.

AMLX : 1.8300 (unch)
BMRN : 77.56 (+0.77%)
EXEL : 20.91 (-1.51%)
2 Incredible Growth Stocks Near 52-Week Lows to Buy Now

These two high-tech bio companies may be too cheap to ignore right now.

VUG : 350.63 (+0.09%)
AMLX : 1.8300 (unch)
VERV : 5.98 (-6.27%)
Why Shares of Amylyx Pharmaceuticals Were Up Monday

The company got a bump from an analyst's upgrade.

GS : 467.72 (+0.69%)
AMLX : 1.8300 (unch)
Stocks Set to Open Higher as Investors Await Fed Meeting, Big Tech Earnings

September S&P 500 futures (ESU23) are up +0.24%, and September Nasdaq 100 E-Mini futures (NQU23) are up +0.32% this morning as investors looked ahead to the Federal Reserve’s interest rate decision while...

ESU23 : 4,491.72s (-0.32%)
NQU23 : 15,435.20s (-0.28%)
AXP : 242.82 (+0.62%)
IPG : 31.78 (+0.47%)
SLB : 48.59 (+0.35%)
ALV : 125.18 (-0.82%)
GOOGL : 176.06 (+1.08%)
META : 471.91 (-0.28%)
MSFT : 420.21 (-0.19%)
RYA.I.DX : 18.305 (-1.27%)
VOD.LN : 77.180 (-0.44%)
AMC : 4.40 (-5.17%)
Better Growth Stock: Amylyx Pharmaceuticals or Viking Therapeutics?

Which of these red-hot biotech stocks is the better buy right now?

AMLX : 1.8300 (unch)
VKTX : 67.00 (-2.98%)
Amylyx Pharmaceuticals Turns Profitable On Successful Drug Launch

Amylyx Pharmaceuticals is the rare young biotech that's profitable. The company earned $0.02 a share in Q1, and analysts expect profitability to grow.

AMLX : 1.8300 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Amylyx Pharmaceuticals Inc. is a clinical-stage pharmaceutical company. It focuses on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. Amylyx Pharmaceuticals Inc. is based in CAMBRIDGE, Mass.

See More

Key Turning Points

3rd Resistance Point 1.9233
2nd Resistance Point 1.8967
1st Resistance Point 1.8633
Last Price 1.8300
1st Support Level 1.8033
2nd Support Level 1.7767
3rd Support Level 1.7433

See More

52-Week High 27.9900
Fibonacci 61.8% 17.9472
Fibonacci 50% 14.8450
Fibonacci 38.2% 11.7428
Last Price 1.8300
52-Week Low 1.7000

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar